RETURN TO PLAY PROTOCOL (Phase 5: RETURN to LOCAL COMPETITION)
Environmental Context. Training grounds and facilities are open, there are no local restrictions on the size of group gatherings, and Phase 4 has been completed for at least 2 weeks. Specific guidelines for return to local competition will be included in a separate document issued later, and additional guidelines will be subsequently provided for planning for travel competitions.
Symptoms of COVID-19 Infection:
Individuals with COVID-19 can exhibit symptoms ranging from mild to life-threatening. The most common symptoms associated with infection include:
· Fever (greater than or equal to 100.4° F)
· Shortness of breath
Less common symptoms that may still be evidence of COVID-19 infection include:
· Sore throat
· Nausea and vomiting
· Muscle / joint pain
· Sudden loss of taste or smell
Return to Play Following Confirmed or Suspected COVID-19 Infection
These recommendations are intended to guide decision-making regarding players or staff with a suspected of documented COVID-19 infection in order to reduce the risk of disease transmission.
Symptomatic player / staff with suspected or laboratory-confirmed COVID-19 infection:
· Cannot attend club events until:
a) At least 3 days (72 hours) have passed since resolution of fever (defined as greater than or equal to 100.4° F) without the use of fever-reducing medications and respiratory symptoms (e.g., cough, shortness of breath), AND…
b) At least 10 days have passed since symptoms first appeared.
c) Resolution of fever without the use of fever-reducing medications, AND
d) Improvement in respiratory symptoms (e.g., cough, shortness of breath), AND…
e) Negative results of an FDA authorized molecular assay for detection of SARS-CoV-2 RNA from at least two consecutive respiratory specimens collected ≥24 hours apart (two negative specimens).
Player / staff with laboratory-confirmed COVID-19 who have not had any symptoms:
· Cannot attend club events until:
a) 10 days after date of their first positive COVID-19 diagnostic test assuming no symptoms since that time. If symptoms develop symptoms, then management should be guided as above for symptomatic individuals.
b) Negative results of an FDA authorized SARS-CoV-2 RNA test from at least two consecutive respiratory specimens collected greater than or equal to 24 hours apart (two negative specimens).
Return to Play Following Exposure to a Suspected or Diagnosed Case of COVID-19
These recommendations are intended to guide decision-making regarding players or staff following exposure to a suspected or diagnosed case of COVID-19 infection in order to reduce the risk of disease transmission.
Any asymptomatic player or staff member who has been exposed to an individual with a suspected or diagnosed case of COVID-19 should be restricted from participation for at least 14 days and monitor for any symptoms consistent with infection.
If asymptomatic after 14 days since last exposure, they can return to participation. In general, you need to be in close contact with an individual to contract the disease. In this case, exposure means any one of the following:
· Caring for a sick person with a suspected or confirmed COVID-19 infection.
· Living in the same household as an individual with a suspected or confirmed COVID-19 infection.
· Being within 6 feet of an individual with a suspected or confirmed COVID-19 infection for around 10 minutes or more.
· Coming in direct contact with secretions from an individual with a suspected or confirmed COVID-19 infection (being coughed or sneezed on, sharing water bottle or utensils, for example).